Wyss Institute
Menu
Search Site
Technologies
Team
News
Events
Multimedia
Search
Search results
4 Results for 'Cancer Vaccine'
Technologies
(1)
Team
(0)
News
(3)
Events
(0)
Multimedia
(0)
Publications
(0)
Jobs
(0)
Technologies
1
Implantable cancer vaccine
The Wyss Institute’s implantable, biodegradable cancer vaccine leverages immunotherapeutic methods and could one day help overcome melanoma, other cancers, infectious diseases, auto-immune diseases, as well as vaccinate against specific peptides, proteins, or antigens. The implant is a biodegradable polymer scaffold containing growth factors and components of each patient’s tumors. The technology was initially designed to...
News
3
Translation News
Harvard bioengineers’ biomaterial-based cancer immunotherapies to be developed by Novartis
March 20, 2018
Press Release
Inciting an immune attack on cancer cells
August 25, 2015
Translation News
Cross-disciplinary team from Harvard University and Dana-Farber Cancer Institute brings novel therapeutic cancer vaccine to human clinical trials
September 6, 2013
Close search results
Technologies
Team
News
Events
Multimedia
Contact
Careers
Resources
Publications
Wiki Login
Close menu
Implantable cancer vaccine 
